These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15530052)

  • 1. In situ gelling of alginate/pluronic solutions for ophthalmic delivery of pilocarpine.
    Lin HR; Sung KC; Vong WJ
    Biomacromolecules; 2004; 5(6):2358-65. PubMed ID: 15530052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbopol/pluronic phase change solutions for ophthalmic drug delivery.
    Lin HR; Sung KC
    J Control Release; 2000 Dec; 69(3):379-88. PubMed ID: 11102678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheological properties of aqueous Pluronic-alginate systems containing liposomes.
    Grassi G; Crevatin A; Farra R; Guarnieri G; Pascotto A; Rehimers B; Lapasin R; Grassi M
    J Colloid Interface Sci; 2006 Sep; 301(1):282-90. PubMed ID: 16777132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin.
    Liu Z; Li J; Nie S; Liu H; Ding P; Pan W
    Int J Pharm; 2006 Jun; 315(1-2):12-7. PubMed ID: 16616442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
    Al-Kassas RS; El-Khatib MM
    Drug Deliv; 2009 Apr; 16(3):145-52. PubMed ID: 19514974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of postsurgical tissue adhesion by anti-inflammatory drug-loaded pluronic mixtures with sol-gel transition behavior.
    Oh SH; Kim JK; Song KS; Noh SM; Ghil SH; Yuk SH; Lee JH
    J Biomed Mater Res A; 2005 Mar; 72(3):306-16. PubMed ID: 15654699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug delivery.
    Wu H; Liu Z; Peng J; Li L; Li N; Li J; Pan H
    Int J Pharm; 2011 May; 410(1-2):31-40. PubMed ID: 21397671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.
    Miyazaki S; Suzuki S; Kawasaki N; Endo K; Takahashi A; Attwood D
    Int J Pharm; 2001 Oct; 229(1-2):29-36. PubMed ID: 11604255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide.
    Vandamme TF; Brobeck L
    J Control Release; 2005 Jan; 102(1):23-38. PubMed ID: 15653131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pluronic F127-g-poly(acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system.
    Ma WD; Xu H; Wang C; Nie SF; Pan WS
    Int J Pharm; 2008 Feb; 350(1-2):247-56. PubMed ID: 17961940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ gelling gelrite/alginate formulations as vehicles for ophthalmic drug delivery.
    Liu Y; Liu J; Zhang X; Zhang R; Huang Y; Wu C
    AAPS PharmSciTech; 2010 Jun; 11(2):610-20. PubMed ID: 20354916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pluronic block copolymers and Pluronic poly(acrylic acid) microgels in oral delivery of megestrol acetate.
    Alakhov V; Pietrzynski G; Patel K; Kabanov A; Bromberg L; Hatton TA
    J Pharm Pharmacol; 2004 Oct; 56(10):1233-41. PubMed ID: 15482637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property.
    Ma WD; Xu H; Nie SF; Pan WS
    Drug Dev Ind Pharm; 2008 Mar; 34(3):258-66. PubMed ID: 18363141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier.
    Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB
    Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ gelling systems based on Pluronic F127/Pluronic F68 formulations for ocular drug delivery.
    Al Khateb K; Ozhmukhametova EK; Mussin MN; Seilkhanov SK; Rakhypbekov TK; Lau WM; Khutoryanskiy VV
    Int J Pharm; 2016 Apr; 502(1-2):70-9. PubMed ID: 26899977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma.
    Gupta S; Samanta MK
    Pharm Dev Technol; 2010; 15(4):386-93. PubMed ID: 19772380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine.
    Lai JY; Hsieh AC
    Biomaterials; 2012 Mar; 33(7):2372-87. PubMed ID: 22182746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release.
    Rupenthal ID; Green CR; Alany RG
    Int J Pharm; 2011 Jun; 411(1-2):69-77. PubMed ID: 21453762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of carbopol-methyl cellulose based sustained-release ocular delivery system for pefloxacin mesylate using rabbit eye model.
    Sultana Y; Aqil M; Ali A; Zafar S
    Pharm Dev Technol; 2006; 11(3):313-9. PubMed ID: 16895842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
    Wittaya-areekul S; Kruenate J; Prahsarn C
    Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.